Patent and trademark agency Papula-Nevinpat has acquired Heinänen Oy Patent Agency

21.5.2019

Papula-Nevinpat reinforces its position as one of Finland’s leading IP firms

Papula-Nevinpat has acquired Heinänen Oy Patent Agency. With the acquisition, all shares of Heinänen Oy Patent Agency are transferred to Papula-Nevinpat. Heinänen Oy Patent Agency will continue to operate under its own name until further notice.

”Competition in the IP field is increasing in Finland, for instance due to legal changes. As our business is growing, we are also constantly on the lookout for new IP experts. This acquisition gives us a good opportunity to expand our business relationships, also on the global market. We warmly welcome the IP experts from Heinänen Oy Patent Agency to our team”, says Markku Simmelvuo, Managing Director from Papula-Nevinpat.

Heinänen Oy Patent Agency is a medium-sized intellectual property agency in Finland. Their long experience and established business model provide a solid basis for excellent customer service. Heinänen Oy Patent Agency was founded in 1969, and has ever since served customers in all intellectual property matters globally.

News

Helsinki head office closed for Ascension Day 13 May 2021

Kindly note that our Helsinki head office will be closed for Ascension Day on Thursday 13 May 2021 and will be fully operational again on Friday 14 May 2021.

Folke Johansson, Markku Simmelvuo and Marina Smirnova named as WIPR Leaders 2021

Papula-Nevinpat’s Folke Johansson, Markku Simmelvuo and Marina Smirnova have again been named as IP Leaders in the 2021 edition of World Intellectual Property Review’s WIPR Leaders.

How Halton uses IPR to keep fresh air flowing indoors

Halton has been providing indoor air solutions since the 1960s. With Papula-Nevinpat’s help, the company has built an IP and trademark portfolio for some of the world’s most advanced indoor air technology.

Patenting pharmaceuticals in Russia – what to know

The last episode in our spring 2021 Russia-Eurasia IP webinar series covered pharmaceutical patenting in Russia. The article includes the main points you should know.